Sun Pharma to buy DUSA

Article

Sun Pharmaceutical Industries, based in India, will acquire DUSA Pharmaceuticals, aiming to advance into the dermatologic market in the United States.

Related Videos
Related Content

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies

October 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

A Hairy Q&A With Jerry Shapiro, MD

September 30th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023
© 2023 MJH Life Sciences

All rights reserved.